Stantec (STN) Matches Q2 Earnings Estimates

Stantec (STN) reported Q2 earnings of $0.98 per share, aligning with consensus estimates and marking an increase from $0.82 year-over-year. Quarterly revenue reached $1.15 billion, missing the Zacks Consensus Estimate by 2.42% but still representing growth from $1.09 billion in the prior year. Despite the slight revenue miss, Stantec shares have significantly outperformed the market, gaining 39.2% year-to-date against the S&P 500's 9.6%, and currently hold a Zacks Rank #2 (Buy), suggesting potential near-term outperformance, with future price sustainability contingent on management's commentary.

Analysis

Stantec (STN) delivered mixed results for the quarter ended June 2025, with earnings per share of $0.98 meeting the Zacks Consensus Estimate and representing a 19.5% increase from the prior year's $0.82. However, quarterly revenues of $1.15 billion, while up 5.5% year-over-year from $1.09 billion, missed consensus estimates by 2.42%. This revenue miss is notable as the company had surpassed revenue expectations in three of the last four quarters. Despite this, the stock's performance has been exceptionally strong, with a 39.2% gain year-to-date, far outpacing the S&P 500's 9.6% increase. The company entered the earnings season with a favorable Zacks Rank #2 (Buy) and benefits from its position within the Consulting Services industry, which ranks in the top 28% of all Zacks-ranked industries. The key variable for the stock's near-term trajectory is management's forthcoming commentary on the earnings call, which will need to address the revenue shortfall and provide confidence in future earnings expectations, currently estimated at $1.11 EPS for the next quarter.

Key Decisions for Investors

• Investors should closely scrutinize management's commentary on the upcoming earnings call for an explanation of the 2.42% revenue miss and for guidance on future growth, which will be critical for sustaining the stock's momentum.
• Given the stock's significant 39.2% year-to-date outperformance, the mixed results warrant a review of positions; the strong EPS growth supports maintaining exposure, but the revenue miss introduces a new risk factor to monitor.
• It is prudent to watch for any revisions to consensus earnings estimates in the days following the report, as the direction of these changes serves as a strong indicator of the market's updated outlook and potential near-term stock performance.